Aehr Test Systems (NASDAQ:AEHR) and C3.ai (NYSE:AI) both aim to capitalize on the artificial intelligence boom, but they operate on opposite ends of the technological spectrum. Which is the better buy?
Aehr focuses on the hardware side, providing essential testing equipment for chips used in high-growth markets like electric vehicles and data centers. C3.ai provides the software layer, helping massive organizations deploy predictive artificial intelligence applications. Both companies are navigating a shifting landscape where rapid innovation meets lumpy revenue cycles.
Aehr Test Systems designs and sells specialized equipment used to test chips at the wafer level to identify defects before they reach final ***** embly. The company is a niche player among semiconductor stocks, providing essential testing equipment for silicon carbide chips. Customer concentration like this adds a layer of risk to the business, as its five largest customers accounted for roughly 70% of net revenues in fiscal 2026.
In FY 2026, revenue reached close to $50.0 million, representing a decline of approximately 15.2% compared to the previous year. This revenue drop contributed to a net loss of roughly $7.1 million for the period. The net margin, which shows how much of each dollar earned becomes profit after all expenses, was nearly -14.3%.
As of its May 2026 balance sheet, the company maintains a current ratio of approximately 10.3x. The current ratio measures a firm's ability to cover short-term debts with short-term ***** ets, with a higher number generally suggesting better liquidity. The debt-to-equity ratio is roughly 0.0x, indicating the company holds negligible debt relative to its shareholder equity while free cash flow was nearly -$5.4 million.
#test #ratio
Aehr focuses on the hardware side, providing essential testing equipment for chips used in high-growth markets like electric vehicles and data centers. C3.ai provides the software layer, helping massive organizations deploy predictive artificial intelligence applications. Both companies are navigating a shifting landscape where rapid innovation meets lumpy revenue cycles.
Aehr Test Systems designs and sells specialized equipment used to test chips at the wafer level to identify defects before they reach final ***** embly. The company is a niche player among semiconductor stocks, providing essential testing equipment for silicon carbide chips. Customer concentration like this adds a layer of risk to the business, as its five largest customers accounted for roughly 70% of net revenues in fiscal 2026.
In FY 2026, revenue reached close to $50.0 million, representing a decline of approximately 15.2% compared to the previous year. This revenue drop contributed to a net loss of roughly $7.1 million for the period. The net margin, which shows how much of each dollar earned becomes profit after all expenses, was nearly -14.3%.
As of its May 2026 balance sheet, the company maintains a current ratio of approximately 10.3x. The current ratio measures a firm's ability to cover short-term debts with short-term ***** ets, with a higher number generally suggesting better liquidity. The debt-to-equity ratio is roughly 0.0x, indicating the company holds negligible debt relative to its shareholder equity while free cash flow was nearly -$5.4 million.
#test #ratio
3 months ago
